CGI Board Of Directors

R.S.K. Chaganti, Ph.D. – Founder and Chairman of the Board

Dr. Chaganti is an internationally recognized leader in cancer cytogenetics and molecular genetics, and holds several patents through Memorial Sloan Kettering Cancer Center as well as Cancer Genetics. He holds the William E. Snee Chair in the Department of Medicine and Cell Biology Program at MSKCC, whose Cytogenetics Service he established in 1976. Dr. Chaganti has served on the boards of many prestigious journals, and has received numerous honors throughout his career, including the Fellowship of the American Association for Advancement of Science and the Founding Fellowship of the American College of Medical Genetics.

Riccardo Dalla-Favera, M.D.

Mr. Dalla-Favera is the Director of the Institute for Cancer Genetics at Columbia University and the Percy and Joanne Uris Professor of Pathology and Genetics and Development (Columbia University Medical School), in addition to serving as the Director of the Institute for Cancer Research at Columbia University. He currently is a member of the Scientific Advisory Boards of the Yale Cancer Center of the Albert Einstein College of Medicine Cancer Center and of the Lymphoma Research Foundation.

Andrew Pecora, M.D.

Mr Pecora presently serves as the Director of Hematology and Oncology and Chief of the Adult Blood and Marrow Stem Cell Transplant Service of Hackensack University Medical Center, as well as Managing Partner of the Northern New Jersey Cancer Center (NJCC). In addition to his numerous advisory appointments, Dr. Pecora also is Chairman, CEO and Chief Medical Officer of Progenitor Cell Therapies, and received his medical degree from University of Medicine and Dentistry of New Jersey, where he is also a clinical professor.

Edmund M. Cannon

Mr Cannon is the founder and President of the Clinical Research Center of Cape Cod, which specializes in finding institutional review board approved, consented specimens for the diagnostics and pharmaceutical industries and setting up studies for Federal Drug Administration submissions for pharmaceutical and biotech research. Mr. Cannon formerly was a Marketing and Operations consultant for Franey Medical Labs, headed sales for Pharmacia Diagnostics, and was Vice President and co-founder of Alletess, Inc.

John Pappajohn

Mr. Pappajohn is a pioneer in the venture capital industry, in 1969 Mr. Pappajohn organized Equity Dynamics, Inc., a financial consulting entity, and Pappajohn Capital Resources, a venture capital firm in Des Moines, Iowa. Since then, Mr. Pappajohn has been involved in over 100 start up companies, and has served as a director of over 40 public companies, many in the bio-science and health related industries. He joined the Board of Directors of CGI in April of 2008.

Tommy G. Thompson

Mr. Thompson is the former Health and Human Services Secretary and four-term Governor of Wisconsin, is founding Chairman and Senior Advisor of the Deloitte Center for Health Solutions and a partner at the law firm of Akin, Gump, Strauss, Hauer, & Feld. He also serves as Chairman of the AGA Medical Corporation. Secretary Thompson is building on his efforts to develop innovative solutions to the health care challenges facing American families, businesses, communities, states and the nation as a whole.